Index -
P/E 26.40
EPS (ttm) 3.79
Insider Own 0.61%
Shs Outstand 51.00M
Perf Week 1.93%
Market Cap 5.01B
Forward P/E 17.41
EPS next Y 5.74
Insider Trans -0.55%
Shs Float 49.82M
Perf Month 4.47%
Income 195.00M
PEG 1.16
EPS next Q 1.43
Inst Own 92.72%
Short Float 1.79%
Perf Quarter 8.42%
Sales 2.11B
P/S 2.37
EPS this Y 12.29%
Inst Trans -0.50%
Short Ratio 2.76
Perf Half Y 29.97%
Book/sh 62.52
P/B 1.60
EPS next Y 26.54%
ROA 3.02%
Short Interest 0.89M
Perf Year 10.57%
Cash/sh 10.29
P/C 9.71
EPS next 5Y 22.76%
ROE 5.72%
52W Range 70.82 - 100.52
Perf YTD 18.54%
Dividend Est. 1.60 (1.60%)
P/FCF 14.74
EPS past 5Y 13.52%
ROI 4.27%
52W High -0.57%
Beta 0.91
Dividend TTM 1.54 (1.54%)
Quick Ratio 1.94
Sales past 5Y -2.65%
Gross Margin 20.27%
52W Low 41.12%
ATR (14) 1.71
Dividend Ex-Date May 31, 2024
Current Ratio 3.15
EPS Y/Y TTM 381.04%
Oper. Margin 3.32%
RSI (14) 65.70
Volatility 1.25% 2.01%
Employees 3800
Debt/Eq 0.46
Sales Y/Y TTM -12.15%
Profit Margin 9.24%
Recom 1.67
Target Price 110.00
Option/Short Yes / Yes
LT Debt/Eq 0.46
EPS Q/Q 42.20%
Payout 42.88%
Rel Volume 0.59
Prev Close 100.29
Sales Surprise 0.06%
EPS Surprise 11.01%
Sales Q/Q -4.64%
Earnings Apr 30 AMC
Avg Volume 323.12K
Price 99.94
SMA20 2.80%
SMA50 3.71%
SMA200 15.30%
Trades
Volume 112,517
Change -0.34%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-11-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$100 → $112
Mar-14-24 Upgrade
Jefferies
Hold → Buy
$100 → $126
Mar-01-24 Initiated
Wolfe Research
Outperform
$108
Jun-29-23 Downgrade
Evercore ISI
Outperform → In-line
Jun-26-23 Downgrade
BMO Capital Markets
Outperform → Market Perform
$109 → $90
Feb-02-23 Downgrade
JP Morgan
Neutral → Underweight
$104 → $105
Sep-12-22 Initiated
Credit Suisse
Outperform
$120
Jan-20-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$120 → $110
Nov-11-21 Downgrade
Monness Crespi & Hardt
Buy → Neutral
Oct-13-21 Initiated
Mizuho
Buy
$116
Jul-30-21 Upgrade
JP Morgan
Underweight → Neutral
$90
Jun-18-21 Initiated
Stifel
Buy
$118
May-04-21 Downgrade
JP Morgan
Neutral → Underweight
$88 → $89
Mar-15-21 Resumed
Credit Suisse
Outperform
$103
Feb-05-21 Reiterated
Monness Crespi & Hardt
Buy
$88 → $100
Sep-22-20 Initiated
Evercore ISI
In-line
Jul-30-20 Reiterated
Monness Crespi & Hardt
Buy
$80 → $88
May-07-20 Upgrade
JP Morgan
Underweight → Neutral
$68 → $62
Apr-17-20 Reiterated
Monness Crespi & Hardt
Buy
$88 → $80
Apr-13-20 Upgrade
BMO Capital Markets
Market Perform → Outperform
$87 → $75
Show Previous Ratings
May-17-24 09:25AM
May-09-24 11:03AM
May-08-24 05:01PM
09:50AM
May-07-24 05:01PM
07:00AM
Loading…
07:00AM
06:59AM
May-06-24 09:40AM
May-02-24 04:02PM
08:45AM
03:17AM
May-01-24 04:52PM
Apr-30-24 09:53PM
06:32PM
05:13PM
(Associated Press Finance)
05:01PM
Loading…
05:01PM
Apr-18-24 06:59AM
Apr-15-24 06:59AM
Apr-11-24 11:13AM
Apr-03-24 05:01PM
Mar-28-24 04:05PM
Mar-08-24 06:59AM
Feb-29-24 11:30AM
Feb-06-24 12:20PM
Feb-01-24 10:12AM
01:20AM
(Thomson Reuters StreetEvents)
Jan-31-24 07:17PM
10:54AM
Jan-30-24 07:00PM
05:42PM
05:11PM
Loading…
05:11PM
(Associated Press Finance)
05:01PM
Jan-29-24 09:16AM
Jan-22-24 05:01PM
Jan-16-24 05:00PM
Jan-09-24 07:00AM
Dec-08-23 11:30AM
Dec-04-23 07:00AM
Nov-30-23 07:00AM
Nov-23-23 01:04PM
Nov-21-23 12:20PM
07:00AM
Nov-14-23 05:25PM
Nov-13-23 05:00PM
Nov-09-23 06:55AM
Nov-08-23 07:55PM
(Associated Press Finance)
05:58PM
05:00PM
Nov-01-23 05:00PM
Oct-26-23 06:01AM
Oct-25-23 06:23AM
Sep-26-23 06:01AM
Sep-12-23 11:33AM
Aug-28-23 07:00AM
Aug-26-23 12:57PM
Aug-25-23 08:09AM
04:30AM
Aug-24-23 06:14AM
Aug-17-23 05:00PM
07:57AM
05:00AM
Aug-16-23 05:51AM
Aug-14-23 07:00AM
Aug-08-23 07:44AM
Aug-02-23 07:10AM
06:55AM
Market Digest: CCI, CCI, ASH, ITW, MAR, MDC, SHEL, SANM, LEA, ANET, ELAN
(Argus Research)
Jul-31-23 09:26AM
Jul-27-23 07:00AM
01:10AM
(Thomson Reuters StreetEvents)
Jul-26-23 09:08AM
Jul-25-23 05:36PM
05:12PM
06:55AM
Jul-19-23 03:13AM
Jul-14-23 07:00AM
Jul-13-23 09:00AM
Jul-11-23 04:24AM
Jul-03-23 08:13AM
Jun-29-23 11:43AM
Jun-28-23 05:00PM
Jun-26-23 05:00PM
Jun-14-23 08:40AM
Jun-01-23 11:31AM
May-29-23 03:33PM
May-17-23 07:07AM
May-15-23 06:04AM
May-11-23 05:15PM
May-10-23 07:35AM
07:20AM
May-05-23 07:42AM
May-02-23 05:32PM
05:15PM
May-01-23 07:00AM
Apr-30-23 10:47AM
Apr-21-23 07:00AM
Apr-20-23 05:00PM
Apr-01-23 08:37AM
Mar-30-23 06:10AM
Mar-24-23 09:27AM
Mar-16-23 11:29AM
Ashland, Inc. engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is involved in pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment consists of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment focuses on rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment refers to production of 1,4 butanediol and related derivatives, including n-methylpyrrolidone. The company was founded in 1924 and is headquartered in Wilmington, DE.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MUSA OSAMA M SVP and CTO May 08 '24 Option Exercise 59.56 9,698 577,632 27,861 May 09 07:37 PM MINICUCCI JAMES P. SVP and GM, Personal Care May 08 '24 Option Exercise 97.56 1,364 133,072 1,364 May 20 04:15 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Feb 16 '24 Sale 92.54 844 78,104 2,883 Feb 20 04:15 PM CHONG MIN SVP, Gen. Mgr. Jan 02 '24 Option Exercise 83.70 6,900 577,530 14,800 Jan 04 06:01 PM BONI ERIC N Principal Accounting Officer Dec 07 '23 Sale 82.38 843 69,446 13,072 Dec 08 07:18 PM BONI ERIC N Principal Accounting Officer Dec 06 '23 Option Exercise 47.63 843 40,152 13,915 Dec 08 07:18 PM MUSA OSAMA M Sr. Vice President Nov 28 '23 Option Exercise 47.36 2,825 133,792 22,262 Nov 30 05:48 PM NOVO GUILLERMO Chair of the Board and CEO Nov 18 '23 Option Exercise 78.32 6,571 514,641 110,534 Nov 22 06:30 AM WILLIS J KEVIN Sr. VP & CFO Nov 18 '23 Option Exercise 78.32 2,064 161,652 18,016 Nov 21 09:47 PM MUSA OSAMA M Sr. Vice President Nov 18 '23 Option Exercise 78.32 1,112 87,092 19,839 Nov 22 03:28 PM ASHLAND INC. Sr. Vice President Nov 18 '23 Option Exercise 78.32 1,112 87,092 19,839 Nov 21 09:55 PM CHONG MIN SVP, Gen. Mgr. Nov 18 '23 Option Exercise 78.32 889 69,626 8,154 Nov 22 06:30 AM KALYANA SWAMINATHAN ASHOK See Remarks Nov 18 '23 Option Exercise 78.32 869 68,060 3,657 Nov 22 06:30 AM Drury Eileen Sr VP, Human Resources Nov 18 '23 Option Exercise 78.32 540 42,293 4,720 Nov 21 09:22 PM BONI ERIC N Principal Accounting Officer Nov 18 '23 Option Exercise 78.32 267 20,911 13,149 Nov 21 09:20 PM LAMPKIN ROBIN E. SVP, Gen. Counsel & Secretary Nov 18 '23 Option Exercise 78.32 247 19,345 3,801 Nov 21 09:54 PM BOSTAPH KARL R. SVP, OPERATIONS Nov 18 '23 Option Exercise 78.32 247 19,345 5,516 Nov 27 11:45 AM NOVO GUILLERMO Chair of the Board and CEO Nov 17 '23 Option Exercise 76.90 13,934 1,071,525 97,618 Nov 22 06:30 AM WILLIS J KEVIN Sr. VP & CFO Nov 17 '23 Option Exercise 76.90 4,325 332,592 14,698 Nov 21 09:47 PM MUSA OSAMA M Sr. Vice President Nov 17 '23 Option Exercise 76.90 2,368 182,099 17,666 Nov 22 03:28 PM ASHLAND INC. Sr. Vice President Nov 17 '23 Option Exercise 76.90 2,368 182,099 17,666 Nov 21 09:55 PM CHONG MIN SVP, Gen. Mgr. Nov 17 '23 Option Exercise 76.90 1,458 112,120 6,813 Nov 22 06:30 AM KALYANA SWAMINATHAN ASHOK See Remarks Nov 17 '23 Option Exercise 76.90 1,387 106,660 2,498 Nov 22 06:30 AM Drury Eileen Sr VP, Human Resources Nov 17 '23 Option Exercise 76.90 1,026 78,899 4,082 Nov 21 09:22 PM BOSTAPH KARL R. SVP, OPERATIONS Nov 17 '23 Option Exercise 76.90 656 50,446 5,415 Nov 27 11:45 AM BONI ERIC N Principal Accounting Officer Nov 17 '23 Option Exercise 76.90 562 43,218 12,596 Nov 21 09:20 PM LAMPKIN ROBIN E. SVP, Gen. Counsel & Secretary Nov 17 '23 Option Exercise 76.90 385 29,607 3,466 Nov 21 09:54 PM WILLIS J KEVIN Sr.VP &Chief Financial Officer Sep 05 '23 Sale 86.54 7,866 680,724 11,583 Sep 06 04:19 PM WILLIS J KEVIN Sr.VP &Chief Financial Officer Sep 01 '23 Option Exercise 47.63 7,866 374,658 19,449 Sep 06 04:19 PM KALYANA SWAMINATHAN ASHOK Sr VP & Gen Mgr, Life Sciences Aug 03 '23 Option Exercise 89.97 275 24,742 1,313 Aug 07 07:00 PM Drury Eileen SVP and Chief Human Resources Jun 13 '23 Option Exercise 85.90 2,336 200,662 4,028 Jun 15 04:23 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite